Judge Axes 2 Anti-Seizure Drug Patents, Upholds 3 Others
A Delaware federal judge has found that claims in a pair of patents related to epileptic seizure treatment Aptiom were invalid, while at the same time finding that patent challenger Alkem...To view the full article, register now.
Already a subscriber? Click here to view full article